• Contact Us
  • Sign Up
  • TWITTER
Microbiome Times Magazine
  • Human Health
  • Animal Health
  • Phytobiome
  • Finance
    • Finance Articles
    • Microbiome Stocks
  • Drug Database
    • About
    • Login/ Register
  • Issue Archive
  • Advertise

Pharma & Human Health

Finance

Digbi Health Raises $5.4 Million in Series A Funding to Reverse Obesity and Associated Inflammatory Digestive and Skin Illnesses

April 9, 2021 Staff Editor

 Digbi Health, a leader in clinically proven genetics and gut-microbiome based digital care program for managing obesity and associated inflammatory digestive, skin and cardiometabolic illnesses, announced it has completed $5.4 million in Series A funding […]

Finance

Pendulum Therapeutics Raises $54 Million to Meet Surging Customer Demand

April 8, 2021 Staff Editor

Pendulum Therapeutics – a biotech company improving health through products targeting the microbiome – today announced a $54 million investment led by Meritech Capital with participation from existing investors including Sequoia Capital, True Ventures and […]

Finance

Probi and Sinopharm enter strategic partnership in China

March 29, 2021 Staff Editor

Sinopharm will launch three probiotic supplements within the immune health, bone health and iron absorption areas based on Probi’s scientifically proven probiotic strains. Zhang Jian Ge, Director Pharmaceutical & Chemical Division of Sinopharm, states: “Sinopharm […]

Pharma & Human Health

New clinical study aims to prevent type 1 diabetes in children

March 28, 2021 Staff Editor

SINT1A is led by Helmholtz Zentrum Muenchen, and part of the international GPPAD initiative including Prof. Ezio Bonifacio and his team at the Center for Regenerative Therapies Dresden at TU Dresden. Around one in 300 […]

Pharma & Human Health

Enterome Receives FDA IND Clearance for EO2463, an ‘OncoMimic’ based Immunotherapy Targeting Liquid Tumors

March 26, 2021 Staff Editor

ENTEROME SA, a clinical stage biopharmaceutical company developing novel drugs based on its unique ability to de-code molecular interactions in the gut microbiome impacting human health, today announces that it has received Investigational New Drug […]

Pharma & Human Health

Of mice and men and their different tolerance to pathogens

March 23, 2021 Benjamin Boettner

Trillions of commensal microbes live on the mucosal and epidermal surfaces of the body and it is firmly established that this microbiome affects its host’s tolerance and sensitivity of the host to a variety of […]

Finance

4D Pharma Announces Completion of Merger with Longevity Acquisition Corporation and admission of ADS to trading on NASDAQ

March 22, 2021 Staff Editor

4D pharma plc (AIM: DDDD) (“4D” or the “Company”), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, is pleased to announce that its […]

Finance

Sandwalk and General Inception announce their collaboration to develop next-generation microbiome technologies

March 18, 2021 Staff Editor

Sandwalk BioVentures, the strategy firm specialized on microbiome technologies, has announced its collaboration with General Inception, a US-based venture studio focused on co-founding and building science-based companies from concept on. Sandwalk will lead the Microbiome […]

Finance

Microba Life Sciences partners with Unilever to target sleep through the gut microbiome

March 17, 2021 Staff Editor

The Centre for Disease Control and Prevention (CDC) has declared insufficient sleep a ‘public health problem’, with more than one-third of American adults not getting enough sleep on a regular basis. Experts in gut microbiome […]

Pharma & Human Health

Adaptive Phage Therapeutics Announces FDA Clearance of IND Application for PhageBank™ in Treatment of Diabetic Foot Osteomyelitis

March 16, 2021 Staff Editor

Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company dedicated to advancing therapies that address the global rise of multi-drug resistant infections, announced today that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug […]

Animal Health

Novozymes acquires data science platform of Biota to strengthen microbiome R&D capabilities in probiotic development

March 12, 2021 Staff Editor

Novozymes, the world leader in biological solutions, announced the acquisition of the microbiome R&D team and data science platform of Biota. Based in San Diego, US, Biota pioneered industrial genomics using microbiome insights, impacting the […]

Posts navigation

1 2 … 46 »

Microbiome-based Diagnostics & Biomarkers: Free Market Report

Sign Up to Free Newsletter

The Microbiome Drug Database

The Microbiome Drug Landscape report: Promising clinical performance and signs of a maturing industry

Market Reports
October 26, 2020
Abstract Year 2020 has been a pivotal year for microbiome-focused drug companies. This year the industry saw the release of two much-anticipated Phase 3 studies, which showed positive results and set the stage for new [...]

Editor’s Choice

  • Fecal transplant turns cancer immunotherapy non-responders into responders
    February 10, 2021
  • Why microbiota samples should be collected in all clinical trials?
    January 26, 2021
  • Kaleido Biosciences Announces Positive Interim Results of Controlled Study of KB109 in Patients with Mild-to-Moderate COVID-19
    January 20, 2021
  • Poor gut health connected to severe COVID-19, new review shows
    January 18, 2021
  • First Published Clinical Trial Using Live Biotherapeutic Candidate In COVID-19 Patients Suggests Role In Improving Outcomes
    September 25, 2020
Categories
  • Animal Health
  • Editor's Choice
  • Finance
  • Lallemand Health Solutions
  • Market Reports
  • Pharma & Human Health
  • Phytobiome & Environment
  • Premium Content
  • Reports
  • Sponsored Content
  • Uncategorized
  • Video
  • Webinar
sign up

Sign up to the Microbiome Times newsletter